Hadiyah-Nicole Green, Ph.D. Hadiyah-Nicole Green, Ph.D. Assistant Professor Physiology hgreen@msm.edu Medical Education Building Room 343 https://www.linkedin.com/in/hadiyah-nicole-green-phd-8166a8b5 http://www.facebook.com/drhadiyahgreen/ http://twitter.com/drhadiyahgreen

Dr. Hadiyah-Nicole Green completed her bachelor of science in physics with a concentration in optics and minor in mathematics from Alabama A&M University in 1999. She received her master of science in physics with a concentration in Nanobiophotonics in 2009 and her Ph.D. in physics in 2012 from the University of Alabama at Birmingham (UAB). As a student, she received $300,000 in scholarships and fellowships, including the National Physical Science Consortium Fellowship, National Science Foundation Bridge to the Doctorate Fellowship, David and Lucille Packard Foundation Fellowship and AAMU Presidential Scholarship.

Before coming to MSM, Dr. Green served at Tuskegee University as an assistant professor in the department of physics with adjunct appointments in the departments of biological sciences and materials science engineering.  She is a multi-disciplinary physicist who specializes in nanobiophotonics and targeted cancer therapeutics, using lasers, nanoparticles, and antibodies to develop biomarker-specific platforms to target, image, and treat malignant tumors including head and neck and women's cancers.

POSTGRADUATE:

University of Alabama at Birmingham, Birmingham, AL 

¶Ù±ð²µ°ù±ð±ð:Ìý Doctor of Philosophy in Physics



GRADUATE:

University of Alabama at Birmingham

¶Ù±ð²µ°ù±ð±ð:ÌýMaster of Science in Physics



UNDERGRADUATE:

Alabama Agricultural and Mechanical University

Degree: Bachelor of Science in Physics

Donate Now: To contribute to Dr. Green's research, please   then select the designation "Dr. Green's Research Fund"

  1. Green HN, Crockett S, Martyshkin D, Singh KP, Grizzle W, Rosenthal E, Mirov S: A histological evaluation and in vivo assessment of intratumoral NIR photothermal nanotherapy induced tumor regression. International Journal of Nanomedicine. 2014 Nov 5; 9: 5093-102. PMID: 25395847.
  2. Salaam AD, Hwang P, Poonawalla A, Green HN, Jun HW, Dean D: Nanodiamonds enhance therapeutic efficacy of doxorubicin in treating metastatic hormone-refractory prostate cancer. Nanotechnology 2014 Oct 24; 25(42):425103. doi: 10.1088/0957-4484/25/42/425103. Epub 2014 Oct 3. PMID: 25277401.
  3. Salaam AD, Hwang P, McIntosh R, Green HN, Jun HW, Dean D: Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer. Beilstein Journal of Nanotechnology 2014; 5:937-945. doi:10.3762/bjnano.5.107. PMID: 25161829.
  4. Frederick PJ, Green HN, Huang JS, Egger ME, Frieboes HB, Grizzle WE, McNally LR: Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotechnic & Histochemistry 2013 October; 88(7): 403-409. PMID: 23672416.
  5. Green HN, Martyshkin DV, Rodenburg CM, Rosenthal EL, Mirov SB: Gold nanorod bioconjugates for active tumor targeting and photothermal therapy. The Journal of Nanotechnology 2011; (631753): 753-759.
  6. Green HN, Martyshkin DV, Rodenburg CM, Rosenthal EL, Mirov SB: A minimally invasive multifunctional nanoscale system for selective targeting, imaging, and NIR photothermal therapy of malignant tumors. Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III 2011; (7910):79100-79109.
  7. Saini V, Enervold MR, Perez A, Koploy A, Perkins G, Ellisman MH, Green HN, Mirov SB, Zharov VP, Everts M: Targeting nanoparticles to tumors using adenoviral vectors. Technical Proceedings of The Nano Science and Technology Institute Nanotechnology Conference and Trade Show: Biomarkers and Nanoparticles 2007; 2(4): 321-324.